Who to call at CG Oncology, Inc., and when
Fundz watches for the moments CG Oncology, Inc. starts buying, and tells you who to reach.
- An alert the day CG Oncology, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CG Oncology, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CG Oncology, Inc.. With Fundz connected, it knows.
CG Oncology, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
cgoncology.comAI Executive Summary
AI-powered analysis of 8-K filing content
CG Oncology appointed Christina Rossi to its Board of Directors as a Class II director effective November 24, 2025, and Simone Song resigned from the Board and all committees effective immediately, with no disagreement cited. Song's departure creates vacancies in her Audit Committee seat and her Compensation Committee chair role.
Key Takeaways
Christina Rossi joins the Board as a Class II director with an initial term expiring at the 2026 annual meeting of stockholders.
Rossi receives a $45,000 annual director fee, payable quarterly, plus an initial award of 20,889 stock options vesting monthly over three years.
3 more takeaways
Related Filings (6)
6 more filings from CG Oncology, Inc. in the last 90 days
Filing Overview
What This Means
CG Oncology, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.